PROTALEX INC
10KSB, EX-27, 2000-08-25
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: PROTALEX INC, 10KSB, 2000-08-25
Next: SYCONET COM INC, 10QSB, 2000-08-25



<TABLE> <S> <C>

<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              MAY-31-2000
<PERIOD-END>                                   MAY-31-2000
<CASH>                                         560487
<SECURITIES>                                   0
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               560987
<PP&E>                                         164111
<DEPRECIATION>                                 5951
<TOTAL-ASSETS>                                 868070
<CURRENT-LIABILITIES>                          271718
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       965891
<OTHER-SE>                                     (619236)
<TOTAL-LIABILITY-AND-EQUITY>                   868070
<SALES>                                        0
<TOTAL-REVENUES>                               10669
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               261358
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             25991
<INCOME-PRETAX>                                (250689)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (250689)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (250689)
<EPS-BASIC>                                    (.03)
<EPS-DILUTED>                                  (.03)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission